1. AIDS Epidemic Update December 2005. UNAIDS Publication CP125. Available at: http://www.unaids.org (accessed January 5, 2006).
2. Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naïve chronically HIV-1-infected individuals;Louie;AIDS,2003
3. Abacavir: a review of its clinical potential in patients with HIV infection;Hervey;Drugs,2000
4. Kearney BP, Flaherty JF, Sayre JR, et al., Effect of formulation and food on the pharmacokinetics of tenofovir DF [Abstract 3]. Presented at the 2nd International Workshop on Clinical Pharmacology of HIV Therapy, Noordwijk, The Netherlands, April 2–4, 2001.
5. Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens;Hawkins;J Acquir Immune Defic Syndr,2005